Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Glucagon (19-29), human acetate a COOH-terminal fragment processed from glucagon, is a potent and efficient inhibitor of insulin secretion.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 59.00 | |
10 mg | In stock | $ 86.00 | |
25 mg | In stock | $ 167.00 | |
50 mg | In stock | $ 249.00 | |
100 mg | In stock | $ 377.00 | |
200 mg | In stock | $ 563.00 | |
500 mg | In stock | $ 846.00 |
Description | Glucagon (19-29), human acetate a COOH-terminal fragment processed from glucagon, is a potent and efficient inhibitor of insulin secretion. |
In vitro | At concentrations ranging from 0.01 to 1000 pM, glucagon 19-29 dose-dependently (ID50 = 1 pM) inhibited by 80-100% the insulin release triggered by glucose, glucagon, glucagon-like peptide-1-(7-36) amide (tGLP-1), or glibenclamide, but not that induced by carbachol[1]. |
Molecular Weight | 1412.57 |
Formula | C63H93N15O20S |
CAS No. | TP1863L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glucagon (19-29), human acetate TP1863L GPCR/G Protein Glucagon Receptor Glucagon , human Acetate Glucagon (1929), human acetate Glucagon (19 29), human acetate inhibitor inhibit